[Benign prostatic hyperplasia: variability in practice and guide to action based on scientific evidence].
Baile
A
A
Departamento de Sanidad del Gobierno Vasco, Hospital de Cruces, Barakaldo, Bizkaia.
Asua
J
J
Albisu
A
A
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000368:Aged; D000465:Algorithms; D018849:Controlled Clinical Trials as Topic; D003937:Diagnosis, Differential; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006801:Humans; D008297:Male; D008517:Phytotherapy; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011470:Prostatic Hyperplasia / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D011471:Prostatic Neoplasms / Q000175:diagnosis; D016032:Randomized Controlled Trials as Topic
D000317:Adrenergic alpha-Antagonists; D004791:Enzyme Inhibitors; D017430:Prostate-Specific Antigen